By Mill Chart
Last update: Aug 15, 2025
So-Young International Inc. (NASDAQ:SY) reported its unaudited financial results for the second quarter of 2025, delivering mixed performance relative to analyst expectations. The company, which operates China’s leading medical aesthetic services platform, posted revenue of $379.5 million, slightly above the consensus estimate of $373.1 million. However, its earnings per share (EPS) came in at -$0.287, significantly worse than the anticipated -$0.111.
The stock has shown mixed performance in recent weeks:
The sharp pre-market decline suggests that despite the revenue beat, the EPS miss has overshadowed optimism, particularly as investors weigh profitability concerns.
Looking ahead, analysts project:
While the Q3 outlook suggests sequential improvement, the full-year EPS forecast remains in negative territory, raising questions about the company’s path to sustained profitability.
The earnings announcement emphasized So-Young’s position as China’s leading aesthetic treatment platform but did not provide explicit forward guidance. The lack of an outlook may contribute to investor uncertainty, particularly given the widening losses.
For a deeper dive into So-Young’s earnings history and future estimates, see the full earnings and estimates breakdown.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before making decisions.
4.84
-0.26 (-5.1%)
Find more stocks in the Stock Screener